vs
Absci Corp（ABSI）与OmniAb, Inc.（OABI）财务数据对比。点击上方公司名可切换其他公司
OmniAb, Inc.的季度营收约是Absci Corp的12.9倍（$8.4M vs $650.0K）。OmniAb, Inc.净利率更高（-169.3% vs -4548.0%，领先4378.7%）。Absci Corp同比增速更快（-2.3% vs -22.5%）。OmniAb, Inc.自由现金流更多（$-5.7M vs $-29.3M）。过去两年OmniAb, Inc.的营收复合增速更高（48.4% vs -14.9%）
Absci Corp是一家结合合成生物学与人工智能技术的生物技术企业，为全球制药及生物制药合作伙伴提供集成式蛋白质工程解决方案，加速抗体、治疗性蛋白等新型生物候选药物的研发，助力满足未被覆盖的临床医疗需求。
OmniAb, Inc.是一家跨国生物技术企业，拥有专利转基因动物平台及全流程抗体发现解决方案，与全球制药和生物科技公司合作，加速肿瘤、自身免疫病等刚需医疗领域的全人源治疗抗体开发。
ABSI vs OABI — 直观对比
营收规模更大
OABI
是对方的12.9倍
$650.0K
营收增速更快
ABSI
高出20.2%
-22.5%
净利率更高
OABI
高出4378.7%
-4548.0%
自由现金流更多
OABI
多$23.6M
$-29.3M
两年增速更快
OABI
近两年复合增速
-14.9%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $650.0K | $8.4M |
| 净利润 | $-29.6M | $-14.2M |
| 毛利率 | — | — |
| 营业利润率 | -4775.5% | -188.2% |
| 净利率 | -4548.0% | -169.3% |
| 营收同比 | -2.3% | -22.5% |
| 净利润同比 | -2.0% | -8.5% |
| 每股收益（稀释后） | $-0.19 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABSIOABI
| Q4 25 | $650.0K | $8.4M | ||
| Q3 25 | $378.0K | $2.2M | ||
| Q2 25 | $593.0K | $3.9M | ||
| Q1 25 | $1.2M | $4.2M | ||
| Q4 24 | $665.0K | $10.8M | ||
| Q3 24 | $1.7M | $4.2M | ||
| Q2 24 | $1.3M | $7.6M | ||
| Q1 24 | $898.0K | $3.8M |
净利润ABSIOABI
| Q4 25 | $-29.6M | $-14.2M | ||
| Q3 25 | $-28.7M | $-16.5M | ||
| Q2 25 | $-30.6M | $-15.9M | ||
| Q1 25 | $-26.3M | $-18.2M | ||
| Q4 24 | $-29.0M | $-13.1M | ||
| Q3 24 | $-27.4M | $-16.4M | ||
| Q2 24 | $-24.8M | $-13.6M | ||
| Q1 24 | $-22.0M | $-19.0M |
营业利润率ABSIOABI
| Q4 25 | -4775.5% | -188.2% | ||
| Q3 25 | -7977.2% | -810.2% | ||
| Q2 25 | -5293.9% | -416.2% | ||
| Q1 25 | -2351.9% | -453.6% | ||
| Q4 24 | -4477.3% | -147.0% | ||
| Q3 24 | -1698.7% | -473.7% | ||
| Q2 24 | -2104.0% | -214.1% | ||
| Q1 24 | -2616.7% | -593.3% |
净利率ABSIOABI
| Q4 25 | -4548.0% | -169.3% | ||
| Q3 25 | -7594.2% | -738.1% | ||
| Q2 25 | -5155.0% | -407.4% | ||
| Q1 25 | -2234.6% | -438.1% | ||
| Q4 24 | -4358.3% | -121.0% | ||
| Q3 24 | -1610.7% | -392.4% | ||
| Q2 24 | -1948.8% | -179.0% | ||
| Q1 24 | -2447.1% | -498.8% |
每股收益（稀释后）ABSIOABI
| Q4 25 | $-0.19 | $-0.11 | ||
| Q3 25 | $-0.20 | $-0.14 | ||
| Q2 25 | $-0.24 | $-0.15 | ||
| Q1 25 | $-0.21 | $-0.17 | ||
| Q4 24 | $-0.26 | $-0.13 | ||
| Q3 24 | $-0.24 | $-0.16 | ||
| Q2 24 | $-0.22 | $-0.13 | ||
| Q1 24 | $-0.22 | $-0.19 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $144.3M | $25.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $189.4M | $267.0M |
| 总资产 | $216.3M | $300.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ABSIOABI
| Q4 25 | $144.3M | $25.5M | ||
| Q3 25 | $152.5M | $28.5M | ||
| Q2 25 | $38.0M | $18.3M | ||
| Q1 25 | $47.0M | $10.9M | ||
| Q4 24 | $112.4M | $27.6M | ||
| Q3 24 | $38.2M | $27.2M | ||
| Q2 24 | $42.9M | $20.8M | ||
| Q1 24 | $58.8M | $19.1M |
总债务ABSIOABI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $4.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ABSIOABI
| Q4 25 | $189.4M | $267.0M | ||
| Q3 25 | $210.3M | $277.4M | ||
| Q2 25 | $173.4M | $262.1M | ||
| Q1 25 | $198.8M | $273.5M | ||
| Q4 24 | $179.1M | $287.6M | ||
| Q3 24 | $201.3M | $291.7M | ||
| Q2 24 | $221.5M | $294.2M | ||
| Q1 24 | $240.1M | $301.4M |
总资产ABSIOABI
| Q4 25 | $216.3M | $300.9M | ||
| Q3 25 | $245.0M | $309.7M | ||
| Q2 25 | $209.9M | $295.7M | ||
| Q1 25 | $232.4M | $306.2M | ||
| Q4 24 | $213.6M | $325.6M | ||
| Q3 24 | $235.2M | $331.6M | ||
| Q2 24 | $255.5M | $337.3M | ||
| Q1 24 | $274.9M | $352.6M |
负债/权益比ABSIOABI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.02× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-29.2M | $-5.7M |
| 自由现金流经营现金流 - 资本支出 | $-29.3M | $-5.7M |
| 自由现金流率自由现金流/营收 | -4505.4% | -67.8% |
| 资本支出强度资本支出/营收 | 15.8% | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-94.2M | $-37.0M |
8季度趋势，按日历期对齐
经营现金流ABSIOABI
| Q4 25 | $-29.2M | $-5.7M | ||
| Q3 25 | $-25.0M | $-9.8M | ||
| Q2 25 | $-16.9M | $-5.1M | ||
| Q1 25 | $-21.8M | $-15.9M | ||
| Q4 24 | $-17.0M | $-3.9M | ||
| Q3 24 | $-20.7M | $-6.6M | ||
| Q2 24 | $-16.8M | $-12.2M | ||
| Q1 24 | $-17.9M | $-17.0M |
自由现金流ABSIOABI
| Q4 25 | $-29.3M | $-5.7M | ||
| Q3 25 | $-26.0M | $-9.9M | ||
| Q2 25 | $-17.1M | $-5.3M | ||
| Q1 25 | $-21.9M | $-16.1M | ||
| Q4 24 | $-17.0M | $-3.9M | ||
| Q3 24 | $-20.8M | $-6.7M | ||
| Q2 24 | $-17.2M | $-12.9M | ||
| Q1 24 | — | $-18.0M |
自由现金流率ABSIOABI
| Q4 25 | -4505.4% | -67.8% | ||
| Q3 25 | -6876.5% | -444.2% | ||
| Q2 25 | -2883.0% | -136.3% | ||
| Q1 25 | -1854.5% | -387.1% | ||
| Q4 24 | -2554.4% | -36.3% | ||
| Q3 24 | -1221.6% | -161.3% | ||
| Q2 24 | -1352.4% | -169.9% | ||
| Q1 24 | — | -472.5% |
资本支出强度ABSIOABI
| Q4 25 | 15.8% | 0.1% | ||
| Q3 25 | 254.5% | 8.1% | ||
| Q2 25 | 37.6% | 4.2% | ||
| Q1 25 | 2.1% | 5.0% | ||
| Q4 24 | 3.5% | 0.4% | ||
| Q3 24 | 2.8% | 3.6% | ||
| Q2 24 | 26.2% | 9.9% | ||
| Q1 24 | 0.0% | 24.4% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
